1. Ferreira SH. A bradikinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol Chemother 1965; 24: 163–9.
2. Yang HY, Erdos EG, Levin E. A dipeptidyl carboxypeptidase that converts angiotensin-1 and inactivates bradykinin. Biochim Biophis Acta 1970; 214: 374–6.
3. Cushman DW, Ondetti MA. Personal and historical perspectives: History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hyperetension 1991; 17: 589–92.
4. Lopez-Sendon J, Swedberg K, McMurray J et al. Expert consensus 
document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004; 25: 1454–70.
5. Pfeffer JM, Pfeffer M, Braunwald E. Alterations of cardiac performance in rats with established spontaneous hypertension. Am J Cardiol 1979; 44: 994–8.
6. Pfeffer JM, Pfeffer M, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci 1982; 79: 3310–4.
7. Pfeffer M, Pfeffer J et al. Progressive ventricular dilatation and diastolic wall stress in rats with myocardial infarction and failure. Circulation 1982; 66 (suppl. II): 66.
8. Pfeffer M, Pfeffer J et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503–12.
9. Awan N, Evenson M et al. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Am Heart J 1981; 101: 22–31.
10. Pfeffer JM, Pfeffer M, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat Circ Res 1985; 57: 84–95.
11. Pfeffer MA, Braunwald EA, Moyé LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival And Ventricular Enlargement trial. N Engl J Med 1992; 327: 669–77.
12. Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy. Lancet 1993; 342: 821–8.
13. Kober L, Torp-Pedersen C, Carlsen JE et al. for the trandolapril cardiac evaluation (TRACE) study group: a clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 33: 1670–76.
14. Van de Werf et al. for the task force of the management of acute myocardial infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST segment elevation. Eur Heart J 2003; 24: 28–66.
15. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction American College of Cardiology; September 1999.
16. Ambrosioni E, Borghi C, Magnani B. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party. Am J Cardiol 1991 Nov 18; 68 (14): 101D–10D.
17. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. N Engl J Med 1995; 332: 80–5.
18. Borghi C, Ambrosioni E.Survival of Myocardial Infarction Long-term Evaluation-2 Working Party. Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. Am Heart J 2003; 145: 80–7.
19. Borghi C, Ambrosioni E. Effects of zofenopril on myocardial ischemia in post–myocardial infarction patients with preserved left ventricular function: The Survival of Myocardial Infarction Long-term Evaluation (SMILE)–ISCHEMIA study. Am Heart J 2007; 153, Issue 3; 445.e7–445.e14.

А.С.Галявич

Казанский государственный медицинский университет